General Practitioners' Barriers Toward Medication Reviews in Polymedicated Multimorbid Patients: How can a Focus on the Pharmacotherapy in an Outpatient Clinic Support GPs?
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
General Practitioners' Barriers Toward Medication Reviews in Polymedicated Multimorbid Patients : How can a Focus on the Pharmacotherapy in an Outpatient Clinic Support GPs? / Laursen, Jannie; Kornholt, Jonatan; Betzer, Cecilie; Petersen, Tonny S; Christensen, Mikkel B.
I: Health Services Research and Managerial Epidemiology, Bind 5, 2018, s. 1-7.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - General Practitioners' Barriers Toward Medication Reviews in Polymedicated Multimorbid Patients
T2 - How can a Focus on the Pharmacotherapy in an Outpatient Clinic Support GPs?
AU - Laursen, Jannie
AU - Kornholt, Jonatan
AU - Betzer, Cecilie
AU - Petersen, Tonny S
AU - Christensen, Mikkel B
PY - 2018
Y1 - 2018
N2 - Purpose: The aim of this study was to explore whether general practitioners (GPs) experienced barriers toward medication reviews in polymedicated, multimorbid patients, and how a clinical pharmacologist with a focus on pharmacotherapy can support the GPs in an outpatient clinic.Design: The study was descriptive and exploratory and had a qualitative design with a phenomenological/hermeneutic orientation for the interviews.Participants: The study comprised 14 interviews with 14 different GPs from the Capital Region of Denmark.Results: Three themes emerged from the interviews: (1) The care of patients With polypharmacy is challenged by the lack of professional dialogue and collaboration between GPs and hospital-based clinical pharmacologists, (2) the relationship between the patients with polypharmacy and the GP is characterized by care and individual considerations, and (3) the culture encourages adding medication and inhibits dialogue about medication withdrawal even for patients with polypharmacy.Conclusion and implications for practice: This study found that the primary barriers toward multimorbid patients with polypharmacy were the need for communication and teamwork with specialists (cardiologists, neurologists, endocrinologists, etc). Often, GPs felt that the specialists at the hospitals were more concerned about following standards and guidelines regarding specific diseases instead of a more holistic patient approach. To improve management of polypharmacy patients, the GPs suggest that a joint force is necessary, a partner-like relationship with greater transparency regarding information transfer, feedback, and shared decision-making, but also more education in the pharmacological field is essential.
AB - Purpose: The aim of this study was to explore whether general practitioners (GPs) experienced barriers toward medication reviews in polymedicated, multimorbid patients, and how a clinical pharmacologist with a focus on pharmacotherapy can support the GPs in an outpatient clinic.Design: The study was descriptive and exploratory and had a qualitative design with a phenomenological/hermeneutic orientation for the interviews.Participants: The study comprised 14 interviews with 14 different GPs from the Capital Region of Denmark.Results: Three themes emerged from the interviews: (1) The care of patients With polypharmacy is challenged by the lack of professional dialogue and collaboration between GPs and hospital-based clinical pharmacologists, (2) the relationship between the patients with polypharmacy and the GP is characterized by care and individual considerations, and (3) the culture encourages adding medication and inhibits dialogue about medication withdrawal even for patients with polypharmacy.Conclusion and implications for practice: This study found that the primary barriers toward multimorbid patients with polypharmacy were the need for communication and teamwork with specialists (cardiologists, neurologists, endocrinologists, etc). Often, GPs felt that the specialists at the hospitals were more concerned about following standards and guidelines regarding specific diseases instead of a more holistic patient approach. To improve management of polypharmacy patients, the GPs suggest that a joint force is necessary, a partner-like relationship with greater transparency regarding information transfer, feedback, and shared decision-making, but also more education in the pharmacological field is essential.
U2 - 10.1177/2333392818792169
DO - 10.1177/2333392818792169
M3 - Journal article
C2 - 30246058
VL - 5
SP - 1
EP - 7
JO - Health Services Research and Managerial Epidemiology
JF - Health Services Research and Managerial Epidemiology
SN - 2333-3928
ER -
ID: 218668459